- Home
- CXDO vs ENGN Comparison
CXDO vs ENGN Comparison
Compare CXDO & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CXDO
- ENGN
- Stock Information
- Founded
- CXDO 1995
- ENGN 1999
- Country
- CXDO United States
- ENGN Canada
- Employees
- CXDO N/A
- ENGN N/A
- Industry
- CXDO Telecommunications Equipment
- ENGN
- Sector
- CXDO Telecommunications
- ENGN
- Exchange
- CXDO Nasdaq
- ENGN Nasdaq
- Market Cap
- CXDO 171.0M
- ENGN 191.1M
- IPO Year
- CXDO 1998
- ENGN N/A
- Fundamental
- Price
- CXDO $5.57
- ENGN $3.79
- Analyst Decision
- CXDO Strong Buy
- ENGN Buy
- Analyst Count
- CXDO 3
- ENGN 7
- Target Price
- CXDO $8.50
- ENGN $23.29
- AVG Volume (30 Days)
- CXDO 130.6K
- ENGN 68.2K
- Earning Date
- CXDO 08-05-2025
- ENGN 09-09-2025
- Dividend Yield
- CXDO N/A
- ENGN N/A
- EPS Growth
- CXDO 51.44
- ENGN N/A
- EPS
- CXDO 0.09
- ENGN N/A
- Revenue
- CXDO $62,609,000.00
- ENGN N/A
- Revenue This Year
- CXDO $13.10
- ENGN N/A
- Revenue Next Year
- CXDO $10.97
- ENGN N/A
- P/E Ratio
- CXDO $62.73
- ENGN N/A
- Revenue Growth
- CXDO 13.85
- ENGN N/A
- 52 Week Low
- CXDO $3.62
- ENGN $2.65
- 52 Week High
- CXDO $7.34
- ENGN $11.00
- Technical
- Relative Strength Index (RSI)
- CXDO 41.81
- ENGN 55.35
- Support Level
- CXDO $5.55
- ENGN $3.45
- Resistance Level
- CXDO $5.99
- ENGN $3.94
- Average True Range (ATR)
- CXDO 0.20
- ENGN 0.26
- MACD
- CXDO -0.05
- ENGN -0.01
- Stochastic Oscillator
- CXDO 5.49
- ENGN 72.19
About CXDO Crexendo Inc.
Crexendo Inc is a provider of cloud communications, UCaaS, call centers, collaboration services, and other cloud business services. The company operates through two segments: Cloud telecommunications and Software Solutions. Its cloud telecommunications segment offers hardware, software, and unified communication solutions for businesses using IP or cloud technology over any high-speed Internet connection. The Software Solutions segment is involved in revenue generation from software licenses, software maintenance support, and professional services. It generates subscription and maintenance support revenue from customer support and other supportive services. The company offers warranties on its products. It derives a majority of its revenue from the Cloud telecommunications segment.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.